Israel Englander Ideaya Biosciences, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 66,686 shares of IDYA stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,686

Previous 547,637 87.82%

Holding current value

$1.57 Million

Previous $8.97 Million 84.38%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$14.5 - $22.63 $6.97 Million - $10.9 Million	-480,951 Reduced 87.82%	66,686 $1.4 Million
Q1 2025 May 15, 2025	BUY	$16.38 - $26.0 $6.96 Million - $11 Million	424,625 Added 345.19%	547,637 $8.97 Million
Q4 2024 Feb 14, 2025	SELL	$24.79 - $31.98 $5.43 Million - $7.01 Million	-219,069 Reduced 64.04%	123,012 $3.16 Million
Q3 2024 Nov 14, 2024	BUY	$30.37 - $43.05 $2.54 Million - $3.59 Million	83,475 Added 32.28%	342,081 $10.8 Million
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $4.14 Million - $5.23 Million	120,395 Added 87.11%	258,606 $9.08 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $4.73 Million - $6.51 Million	138,211 New	138,211 $6.06 Million
Q1 2023 May 15, 2023	SELL	$13.49 - $18.72 $2.28 Million - $3.17 Million	-169,225 Reduced 90.77%	17,202 $236,000
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $2.7 Million - $3.39 Million	186,427 New	186,427 $3.39 Million
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $215,197 - $360,741	-25,990 Reduced 20.63%	99,982 $1.38 Million
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $1.15 Million - $2.47 Million	102,769 Added 442.91%	125,972 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $266,923 - $342,478	12,741 Added 121.78%	23,203 $549,000
Q3 2021 Nov 15, 2021	SELL	$17.26 - $27.08 $1.95 Million - $3.06 Million	-112,935 Reduced 91.52%	10,462 $267,000
Q2 2021 Aug 16, 2021	BUY	$17.76 - $24.83 $90,309 - $126,260	5,085 Added 4.3%	123,397 $2.59 Million
Q1 2021 May 17, 2021	BUY	$13.48 - $23.77 $439,084 - $774,260	32,573 Added 37.99%	118,312 $2.78 Million
Q4 2020 Feb 16, 2021	SELL	$12.17 - $17.52 $171,487 - $246,874	-14,091 Reduced 14.11%	85,739 $1.2 Million
Q3 2020 Nov 16, 2020	BUY	$11.22 - $14.46 $135,649 - $174,821	12,090 Added 13.78%	99,830 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$3.59 - $18.57 $102,228 - $528,799	28,476 Added 48.05%	87,740 $1.25 Million
Q1 2020 May 14, 2020	BUY	$3.03 - $10.58 $62,333 - $217,651	20,572 Added 53.17%	59,264 $244,000
Q4 2019 Feb 14, 2020	SELL	$5.34 - $9.09 $124,721 - $212,306	-23,356 Reduced 37.64%	38,692 $290,000
Q3 2019 Nov 14, 2019	BUY	$6.06 - $10.91 $112,806 - $203,089	18,615 Added 42.86%	62,048 $558,000
Q2 2019 Aug 15, 2019	SELL	$9.58 - $11.95 $7.62 Million - $9.51 Million	-795,467 Reduced 94.82%	43,433 $433,000
Q2 2019 Aug 14, 2019	BUY	$9.58 - $11.95 $8.04 Million - $10 Million	838,900 New	838,900 $34.2 Million

Others Institutions Holding IDYA

# of Institutions

219

Shares Held

83.4M

Call Options Held

28.7K

Put Options Held

132K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.13B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account